Weba significant proportion of the SYNTHESIS patients lacked a proximal arterial occlusion because 7% of patients had small vessel disease and the median National Institutes of … WebAug 19, 2024 · The Italian synthesis expansion: A randomized controlled trial on IA versus intravenous thrombolysis in acute Ischemic stroke (synthesis expansion) trial, published in 2013, aimed to determine the superiority of IA thrombolysis compared to IV tPA with regard to survival free of disability (mRS 0-1) at 90 days.
Endovascular treatment for acute ischemic stroke - PubMed
WebMay 1, 2014 · In the SYNTHESIS EXPANSION trial, patients in the endovascular arm were treated an hour later than those in the IV arm, with median time between symptom onset … WebThe intervention group in the SYNTHESIS Expansion trial did not receive systemic thrombolysis.6 MR RESCUE was excluded as <50% of the included patients received … dichtheid paracetamol
SYNTHESIS Expansion: design of a nonprofit, pragmatic, …
WebMar 1, 2013 · A real world approach was chosen by the Synthesis Expansion investigators. They tested the hypothesis whether IA treatment is superior to IV treatment irrespective of … WebJan 7, 2014 · In the SYNTHESIS Expansion trial 2, 362 patients with AIS were randomly allocated to endovascular therapy or to intravenous tPA within 4.5 h of symptom … WebThe SYNTHESIS expansion trial, led by Alfonso Ciccone (Carlo Poma Hospital, Mantua, Italy), randomly assigned 362 acute ischemic stroke patients within 4.5 hours of symptom … citizenm technology